Biological and Biomedical Science
 DMS Home  /  About DMS  /  Current Student Resources  /  Contact Us  /  Search 

David Altshuler

Department of Genetics and of Medicine, MGH
Program in Medical and Population Genetics, Broad Institute
Department of Molecular Biology
Center for Human Genetic Research
Massachusetts General Hospital
Richard B. Simches Research Center
185 Cambridge St., Room 6806
Boston, MA 02114
Tel: (617) 726-5940
Email: altshuler@molbio.mgh.harvard.edu
Web Page: The Altshuler Lab Page
Additional Page: http://www.broad.mit.edu/mpg
12 postdoctoral fellows, 2 graduate students, 1 medical student, 5 technicians

David Altshuler

Despite remarkable progress in biomedical research, little is known about the root causes that underlie individual risk of
common diseases. Disease is typically caused by the combination of multiple genes and non-genetic factors; in this setting,
traditional approaches of human genetics have met with limited success. By combining information from human and
population genetics, genomics and epidemiology we are searching for mutations contributing to common, polygenic
diseases, and applying these tools to discover root causes of type 2 diabetes and other disorders in the human population.

One major focus of the lab is to characterize human genome sequence variation. Most human genetic diversity is attributable to common single nucleotide polymorphisms (SNPs), and we have helped create a map that now contains the vast majority of common SNPs in human populations. We have characterized how these SNPs are distributed across the genome and among population, and the origin of these patterns in human history and recombination. We were deeply involved in the International Haplotype Map Consortium, and have contributed to study of copy number variation, the development of tools and methods for genome-wide SNP genotyping and statistical genetics methodologies to relate genotype and phenotype.

A second major focus is to apply these methods to understand type 2 diabetes and other diseases. Until recently these studies met with limited success, because the tools were not available to comprehensively search the genome. Last year we performed a whole genome association study in type 2 diabetes, identifying three novel loci for the disease. In the next year we anticipate a wealth of new clues about genes underlying diabetes and other common diseases, and pursuing these leads would make excellent projects for new graduate students.

Our long-term goal in identifying genetic risk factors is to understand how they contribute to human pathophysiology, and to apply such information to improve diagnosis, prevention, and treatment of disease.

 

References:

  • The International HapMap Consortium (2005) “A haplotype map of the human genome” Nature, 437(7063):1299-320.
  • Florez JC, et al (2006) “TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program” New England Journal of Medicine 2006;355:241-50.
  • Diabetes Genetics Initiative of Broad, Lund and Novartis (2007) “Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels” Science 316:1331-6.
  • Graham RR et al, (2007) “Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus” PNAS 104:6758-63.